Biotech: Page 46
-
PharmaVoice Team/PharmaVoice
Decoding Data Dynamics
By Carolyn Gretton The shift in life-sciences development toward more personalized therapeutics is driving a need for proactive clinical data management (CDM) strategies that take into account the volume and complexity of information emerging from today’s clinical trials. Data management is being...
By Carolyn Gretton • Aug. 29, 2011 -
PharmaVoice Team/PharmaVoice
Hola Mexico: Pharma Drawn to U.S. Neighbor
By Kim Ribbin Growing health coverage, high medical standards, a motivated patient population, and huge geographic advantages make Mexico an appealing market for the pharmaceutical industry. With a population of around 110 million people and a growing focus on healthcare, Mexico has fast becom...
By Kim Ribbink • Aug. 29, 2011 -
Explore the Trendline➔
Getty Images
TrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Beyond Stem Cells
By Denise Myshko It may seem like science fiction: a trachea grown from stem cells and implanted into a human being. But it’s not; this is an actual account of the power of stem cells and regenerative medicine. The 36-year-old patient, who had been suffering from late-stage tracheal cancer, recei...
By Denise Myshko • Aug. 29, 2011 -
PharmaVoice Team/PharmaVoice
Mentoring: More Crucial Than Ever
By Robin Robinson With the industry in constant flux, industry leaders say mentoring is key for career advancement. Declining budgets, the emergence of small innovative startups with fewer resources, busy schedules, and an ever-changing work environment are a few of the factors that make mentorin...
By Robin Robinson • Aug. 29, 2011 -
PharmaVoice Team/PharmaVoice
Last Word
Making Strategic Alliances Work Wa’el Hashad, VP, U.S. Cardiovascular and Metabolic Disorders, at Boehringer Ingelheim Pharmaceuticals, talks about how an alliance with Lilly helped to bring a new product to the diabetes market. PV: What challenges are encountered when developing diabetes produc...
By PharmaVoice Team • Aug. 29, 2011 -
PharmaVoice Team/PharmaVoice
Talent Pool
Executive appointments and promotions in the healthcare industry By Carolyn Gretton Pharmaceutical POOL Dr. Tomas BOCANEGRA Pozen Appoints Development VP Pozen, a pharmaceutical company committed to developing medicines that transform lives, has named Tomas Bocanegra, M.D., executive VP of develo...
By PharmaVoice Team • Aug. 29, 2011 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New electronic and web-based applications, sites, and technologies By Carolyn Gretton Clinical Force Acquisition Strengthens Medidata’s CTMS Offerings Trends: E-clinical solutions providers continue to bolster their clinical trial management solutions (CTMS) offerings as demand surges amid increa...
By Carolyn Gretton • Aug. 29, 2011 -
PharmaVoice Team/PharmaVoice
2011 PharmaVOICE 100 - Who's on the List by Section
The Commanders & Chiefs Frank Baldino Jr., Ph.D. Cephalon Inc. Donna Beardsworth. Beardsworth Group Calep A. (Joe) Boyd III MCS Healthcare Public Relations Randall Carpenter, M.D. Seaside Therapeutics N. Anthony Coles, M.D. Onyx Pharmaceuticals B. Reid Connolly evoke interaction Donna Cryer C...
By PharmaVoice Team • July 26, 2011 -
PharmaVoice Team/PharmaVoice
The Commanders & Chiefs
Frank Baldino Jr., Ph.D. Cephalon Inc. Donna Beardsworth. Beardsworth Group Calep A. (Joe) Boyd III MCS Healthcare Public Relations Randall Carpenter, M.D. Seaside Therapeutics N. Anthony Coles, M.D. Onyx Pharmaceuticals B. Reid Connolly evoke interaction Donna Cryer CryerHe...
By PharmaVoice Team • July 26, 2011 -
PharmaVoice Team/PharmaVoice
Talent Pool
Executive appointments and promotions in the healthcare industry By Carolyn Gretton Pharmaceutical POOL Damian BRAGA Sanofi Pasteur Consolidates Commercial Operations Leadership Sanofi Pasteur, the vaccines division of global healthcare company Sanofi, has tapped U.S. President Damian Braga as s...
By Carolyn Gretton • July 26, 2011 -
PharmaVoice Team/PharmaVoice
On the Calendar
August 6-8 BIT’s 1st Annual World Congress of Molecular & Cell Biology Beijing International Convention Center, Beijing BIT Life Sciences, http://www.bitlifesciences.com/cmcb2011/ August 8-9 Development and Validation of Bioanalytical Assays for Biologics: Quantitation (PK) and Immunogenicit...
By PharmaVoice Team • July 26, 2011 -
PharmaVoice Team/PharmaVoice
What's New
What’s New New healthcare-related products, services, and companies By Carolyn Gretton PPD Expands Product Development Consulting Services Trend: Quick growth in sectors like biosimilars and adaptive trial design have life-sciences companies clamoring for consultants with specific knowledge of t...
By Carolyn Gretton • July 26, 2011 -
PharmaVoice Team/PharmaVoice
2011 PharmaVOICE 100 - Who's on the List by Company
Acorda Therapeutics Andrew Blight, Ph.D. ACT Biotech Inc. Ali Fattaey, Ph.D. Acucela Inc. Ryo Kubota, M.D., Ph.D. Alliance Healthcare Information LLC Mary Anne Greenberg Almac Group Sir Allen McClay The Avoca Group Inc. Patricia Leuchten AXON US Mario Nacinovich Beardsworth Group Donna Beardswort...
By PharmaVoice Team • July 26, 2011 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Taking Inspiration to the Next Level This is our favorite issue of the year, and we hope it’s yours too. It has been a joy and a privilege to have had a chance to get to know this year’s PharmaVOICE 100. They certainly illustrate what it means to think bigger, do more, and lead with passion and i...
By Taren Grom • July 26, 2011 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: A Changing Rhythm
According to Barbara Wirostko, M.D., chief medical officer for Altheos, the question of whether a product candidate will be reimbursed by government and third-party payers is now surfacing in the earliest stages of discovery. “Because there are now issues around who is going to reimburse and who ...
By PharmaVoice Team • May 24, 2011 -
PharmaVoice Team/PharmaVoice
Educating the Scientists of the Future
High-quality science education is critical for the success of pharmaceutical and biotechnology companies, not only to meet the need for scientists in the future but also to foster scientific literacy. Education reform is a hot-button issue for the nation in general and the pharmaceutical industr...
By Denise Myshko • May 24, 2011 -
PharmaVoice Team/PharmaVoice
DIA Preview
New Tools, Services, and Products Designed to Improve Drug Development This special Drug Information Association section highlights the new and innovative products being offered by companies exhibiting at the upcoming 2011 DIA — 47th Annual Meeting in Chicago. (Note: briefs are listed alphabetic...
By PharmaVoice Team • May 24, 2011 -
PharmaVoice Team/PharmaVoice
Last Word
Combating Drug Resistance Roger Pomerantz, M.D., Senior VP and Head of Infectious Disease Research at Merck, talks about why antimicrobial resistance is a major global concern. PV: How big of a problem is antimicrobial resistance? Pomerantz: For the first time since the antibiotic era started in...
By PharmaVoice Team • May 24, 2011 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Dr. Janet HAMMOND Roche Strengthens Translational Medicine Leadership Roche has appointed Janet Hammond, M.D., Ph.D., VP, translational medicine – virology in pharmaceutical research and early development (pRED). Dr. Hammond joins Roche from Valeant Pharmaceuticals Internation...
By PharmaVoice Team • May 24, 2011 -
PharmaVoice Team/PharmaVoice
Ahn Nyeong: South Korea Emerges
In just three years, South Korea has been reclassified from an emerging market to a developed market by IMS. This is based on South Korea’s GDP level, as well as a well-established and growing economy, rising income levels, better living conditions, and an improved healthcare system that has led ...
By Kim Ribbink • April 25, 2011 -
PharmaVoice Team/PharmaVoice
Partnering for Diagnostics
Molecular diagnostics, one of the fastest growing segments in the diagnostics market, are key enablers in delivering personalized medicine. According to industry consultants, molecular diagnostics are set to become the dominant platform in clinical medicine. But currently only about 10% of labels...
By Denise Myshko • April 25, 2011 -
PharmaVoice Team/PharmaVoice
Creating a Personalized Medicine Strategy
Considered broadly, healthcare is personal. The goal of medical practitioners has always been to get the right drug to the right person at the right time at the right dose. But now industry experts say personalized medicine is at a tipping point as a multitude of factors converge, including advan...
By Denise Myshko • April 25, 2011 -
PharmaVoice Team/PharmaVoice
Last Word
John Gargiulo, Daiichi Sankyo’s new President and CEO, discusses the future opportunities for the company and the industry. Keeping the Patient Front and Center Last Word PV: What are your goals for Daiichi Sanyko? Gargiulo: The healthcare industry is currently experiencing unprecedented challeng...
By PharmaVoice Team • April 25, 2011 -
PharmaVoice Team/PharmaVoice
UpFront
America’s biopharmaceutical research companies invested a record $67.4 billion last year in R&D, an increase of $1.5 billion. Healthcare Providers Say Pharma Provides Value Almost 8 out of 10 physicians view pharmaceutical companies and their sales reps as useful sources of information on m...
By PharmaVoice Team • April 25, 2011 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
The mHealth Revolution The Statistics are staggering. According to a report by research2guidance, by 2015 one in five people around the world will have a smartphone. Another report states that mobile app revenue is expected to reach $35 billion by 2014. Finally, company investment in mobile phone...
By Taren Grom • April 25, 2011
Previous
